|
Re: RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
3
|
Resverlogix Corp.
|
Nov 25, 2020 09:26AM
|
|
New Zenith poster
|
6
|
Zenith Epigenetics
|
Dec 10, 2020 04:13PM
|
|
Re: Award of deferred shares and restricted shares
|
5
|
Resverlogix Corp.
|
Dec 19, 2020 02:05PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
8
|
Resverlogix Corp.
|
Jan 13, 2021 04:39PM
|
|
Re: Closing on the Saudi deal..
|
1
|
Resverlogix Corp.
|
Jan 15, 2021 08:02PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
3
|
Resverlogix Corp.
|
Jan 18, 2021 07:53AM
|
|
Re: 55 cents
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 18, 2021 06:45PM
|
|
Re: Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2020
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 28, 2021 07:38AM
|
|
Our own BKC on the webcast
|
3
|
Resverlogix Corp.
|
Feb 04, 2021 12:48PM
|
|
Re: Our own BKC on the webcast
|
2
|
Resverlogix Corp.
|
Feb 04, 2021 01:00PM
|
|
Re: JD's Blog
|
3
|
BIOASIS TECHNOLOGIES INC
|
Feb 15, 2021 09:52PM
|
|
News report on last NR
|
13
|
Resverlogix Corp.
|
Mar 05, 2021 07:55PM
|
|
Re: News report on last NR
|
7
|
Resverlogix Corp.
|
Mar 05, 2021 11:08PM
|
|
Re: 25% Pop in SP .... Now $1.12
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 11:35AM
|
|
Re: March Presentation
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 02:39PM
|
|
Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:11PM
|
|
Beyond Therapeutics License Agreement in financials
|
5
|
Zenith Epigenetics
|
Apr 08, 2021 12:48PM
|
|
Re: GV on stock house
|
4
|
Resverlogix Corp.
|
Apr 08, 2021 01:37PM
|
|
New Edison Report
|
5
|
BIOASIS TECHNOLOGIES INC
|
Apr 09, 2021 08:03AM
|
|
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
8
|
Resverlogix Corp.
|
Apr 12, 2021 08:07AM
|
